So-Young International (NASDAQ:SY – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.06, FiscalAI reports. The business had revenue of $74.36 million during the quarter, compared to analyst estimates of $70.40 million. So-Young International had a negative net margin of 13.62% and a negative return on equity of 13.52%.
Here are the key takeaways from So-Young International’s conference call:
- Q2 revenue reached a record RMB 510 million, up 33% year over year, while aesthetic treatment revenue grew approximately 130% to RMB 331.4 million, marking the business’s 10th consecutive quarter of triple-digit growth.
- The clinic network expanded to 65 centers across 18 cities, with 47 centers profitable and 51 generating positive operating cash flow. Aesthetic-center gross margin improved 3.8 percentage points year over year to 28.1%, supported by higher utilization, procurement scale, and operating efficiencies.
- The group’s net loss narrowed 37% year over year to RMB 22.7 million, and management expects further margin improvement in Q3 and Q4 as fixed costs are diluted, the autumn-winter peak season approaches, and resources are shifted toward profitable businesses.
- Management highlighted strong customer engagement, including more than 250,000 active users, over 78,000 core members, and referrals accounting for more than 50% of new customers. The company also plans to launch its first fully intelligent AI-enabled clinic in Q4 to standardize care and improve operational efficiency.
- Other revenue streams weakened, with information and reservation services down 35% year over year, other services down 48.2%, and medical products and maintenance revenue down 2.8%. Q3 aesthetic-treatment revenue guidance of RMB 352 million to RMB 362 million implies growth of 91.7%–97.2%, a notable deceleration from Q2’s pace.
So-Young International Stock Down 5.8%
SY stock opened at $2.74 on Wednesday. The company has a 50-day simple moving average of $1.95 and a 200 day simple moving average of $2.43. The company has a market capitalization of $278.38 million, a P/E ratio of -8.06 and a beta of 2.00. So-Young International has a fifty-two week low of $1.28 and a fifty-two week high of $4.75.
Institutional Investors Weigh In On So-Young International
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings upgraded So-Young International from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 25th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, So-Young International has an average rating of “Sell”.
View Our Latest Research Report on SY
So-Young International Company Profile
So-Young International Inc operates a leading digital marketplace and community platform focused on the medical aesthetic industry in China. Headquartered in Shanghai and founded in 2013, the company connects consumers seeking cosmetic treatments with a network of accredited clinics, licensed physicians and beauty service providers. Its online ecosystem offers a wealth of educational content, peer reviews and before-and-after galleries designed to help users make informed decisions about aesthetic procedures.
The company’s platform is accessible via web and mobile applications, where users can browse service packages, compare providers, read expert articles and schedule appointments directly through an integrated booking system.
Further Reading
- Five stocks we like better than So-Young International
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for So-Young International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for So-Young International and related companies with MarketBeat.com's FREE daily email newsletter.
